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The current refugee crisis emphasizes the need for information on infectious diseases and
resistant microorganisms in asylum seekers with possible consequences for public health
and infection control.
Methods
We collected data from asylum seekers admitted to our university hospital or who presented
at the Emergency Department (n = 273). We collected general and demographic character-
istics including country of origin, the reason of presentation, and the screening results of
multi-drug resistant organisms.
Results
67% of the patients were male with a median age of the study group of 24 years (IQR 15–
33); 48% of the patients had an infectious disease—predominantly malaria with P. vivax or
tuberculosis. Patients also reported with diseases which are less common—e.g. leishmani-
asis, or even conditions rarely diagnosed in Europe—e.g. louse borne relapsing fever. A
carriage rate of 31% for multi-drug resistant microorganisms (MDRO) was observed, with
ESBL-expressing E.coli (n = 20) being the most common MDRO. No carriage of Carbape-
nemase Producing Enterobacteriaceae was found.
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Conclusion
The current refugee crisis in Europe challenges hospitals to quickly identify and respond to
communicable diseases and the carriage of MDRO. A rapid response is necessary to opti-
mize the treatment of infectious diseases amongst asylum seekers to maximize infection
control.
Introduction
The current refugee crisis in Europe challenges both society as a whole and health care workers.
Six hundred and twenty-six thousand people applied for asylum in the 28 European (EU)
Member States in 2014. When compared to 2013, this was an increase of 45%[1]. More than
350,000 refugees reported at the EU borders between January-September 2015. This number
may be an underestimate as many refugees may have remained undetected[2, 3].
Next to travelling, migration is a well-known factor in the spread of infectious diseases and
multi-drug resistant micro-organisms (MDRO) [4]. However, little is known about the carriage
of infectious diseases and MDRO in asylum seekers whenever they report with illness to the
healthcare system in the host country with possible implications for hospital infection control.
The Netherlands have a very active surveillance for MDRO with a very low MDRO preva-
lence among patients admitted to hospital [5]. The overall carriage of extended spectrum beta-
lactamase (ESBL) producing bacteria in the Dutch population is 5.1% [6]. In hospitals the over-
all carriage rate of vancomycin-resistant enterococci (VRE) is 0.4% and the percentage of
methicillin-resistant Staphylococcus aureus (MRSA) is only 2%. Most cases of Carbapenemase-
producing Enterobactereaceae (CPE) in the Netherlands have been reported in patients repatri-
ated from a foreign hospital [7], although some hospital outbreaks have occurred[8]. The Neth-
erlands has a strict hospital infection prevention policy, especially with respect to screening for
patient admissions for those recently admitted to hospitals in foreign countries. Screening pol-
icy does not include travellers and it is currently unclear whether asylum seekers without a
recent hospital admission would need to be screened.
In addition to the carriage of MDRO, asylum seekers may present with infectious diseases
which may have consequences for public health and hospital hygiene; immigrants are known to
have a higher rate of tuberculosis compared to the indigenous population [9,10]. However rates
may vary considerably between countries of origin. The incidence of tuberculosis is 78 per
100.000 inhabitants in Eritrea and 17 per 100.000 inhabitants in Syria [11]. Information on
MDRO carriage in countries of origin is scarce. In Syria the rate of MDR gram negative bacteria
in selected patient populations with clinical infections was around 50–60%. [12, 13].
The spectrum of infectious diseases asylum seekers present with depends on risk factors
such as country of origin, exposure during travel, previous living conditions, and access to
health care and migration routes [14].
Here we report the spectrum of infectious diseases, prevalence of patients carrying MDRO’s
amongst asylum seekers who presented to the University Medical Centre Groningen which is
located close to the national registration centre for asylum seekers in the Netherlands. Our data
may conceivably help improve adequate care for asylum seekers with infectious diseases and
enable optimal hospital hygiene strategies.
Infectious Diseases in Asylum Seekers
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Materials and Methods
Asylum Seeking Procedure in the Netherlands
In 2014 24,929 asylum seekers arrived in the Netherlands, an increase of almost 62% compared
to 2013 (15,394). In the context of the current European refugee crisis, the number of asylum
seekers in 2015 has increased considerably. Since January 2015 up until the beginning of Sep-
tember 2015, 33,598 asylum seekers had already reported at the national registration centre
[15].
The Netherlands operate a centralised system of asylum application. Apart from a small
minority at the national airport Schiphol and unaccompanied minors, the majority of asylum
seekers must file their request at the national registration centre in Ter Apel. Within the first
three days following arrival individuals are identified, registered and screened for active pulmo-
nary tuberculosis. In Spring 2014 a standard preventative treatment of scabies was introduced.
Screening is performed by the municipal health services. All asylum seekers are insured by the
same insurance company and have an insurance number that starts with 9010 as decided by
the insurance company. After this period, asylum seekers move to one of the asylum centres in
the Netherlands to await processing [16].
Screening at Admission to the Hospital
The University Medical Centre Groningen is the university hospital closest to the national reg-
istration centre (60 km) and a preferred carrier for treating infectious diseases. The general
practitioner based at the national registration centre decides whether the asylum seeker is
referred to the regional hospital or the university hospital and for abnormalities found during
TB screening the TB control physician in Groningen decides.
General infection prevention policy in the Netherlands includes screening for MRSA, VRE
and resistant gram-negative bacteria of all patients who admitted to a hospital outside the
Netherlands in the past 2 months.
In April 2014, the department of medical microbiology in the UMCG advised screening for
MRSA, VRE, and multidrug resistant gram negatives for all asylum seekers admitted to the
hospital or who presented at the emergency department (with a high probability of a subse-
quent admission). This advice was only given if admission or outpatient visit was reported. The
reason for screening was the anticipated high carriage rate of MDRO in asylum seekers when
considering their countries of origin. Asylum seekers who were admitted or presented to the
emergency department were screened for carriage of the following MDRO’s: MRSA, ESBL,
fluorquinolone- and aminoglycoside-resistant (MDR) Gram-negative bacteria, VRE, and CPE
as part of standard care.
Carriage of MDRO does not have consequences for hospital hygiene measure in the outpa-
tient setting. Therefore patients only visiting out-patient departments were not included in the
MDRO screening.
Selection of Participants
A retrospective study was conducted at the UMCG. All asylum seekers admitted to the UMCG
or reporting to the emergency department between April 1st 2014 through September 1st 2015
were included. Patients were identified as asylum seekers based on their specific insurance
number. Patients with the specific insurance number but whose asylum request was rejected by
legal authorities as evidenced by the information available in their medical records were not
included. Only asylum seekers who presented at the emergency department or who were
Infectious Diseases in Asylum Seekers
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admitted to the wards, or the tuberculosis department were included. If patients were admitted
more than once, only the first admission in the study period was included.
General characteristics such as age at admission, gender, country of origin, and arrival data
in the Netherlands, admission period and reason of admission were collected. Detailed infor-
mation was collected concerning infectious conditions the patients presented with. The ICD-
10 classification was used to describe the non-infectious diseases patients presented with at the
hospital [17].
Screening for MDRO
Screening for MDRO consisted of swabs from nose, throat, rectum and perineum. MRSA was
tested on nose, throat and perineum swabs with PCR (GeneXpert Cepheid). These swabs were
also cultured on enrichment broth and chromID-MRSA plates (Biomerieux). VRE was
detected as described previously [18]. Presence of MDR Gram-negative bacteria in throat and
rectum swabs was detected by culture on selective agar plates (3-com Iso sensitest agar ME/CF/
CX and CI/TO/PT, Mediaproducts, Groningen, the Netherlands). Antibiotic susceptibility was
tested by automated susceptibility testing (VITEK2, bioMerieux, Marcy l’Etoile, France), or E-
tests (AB Biodisk, Mannheim, Germany) applying EUCAST guidelines. Presumptive ESBL-,
plasmidal AmpC-, or carbapenemase-producing isolates were analysed for presence of resis-
tance genes by a DNA-array (Check-MDR CT103, Check-points, Wageningen, The
Netherlands).
If patients tested positive they were isolated during their stay in the hospital, according to
national and local guidelines. All patients diagnosed with TB or some patients suspected to
have TB are referred directly to the UMCG tuberculosis centre and sanatorium Beatrixoord.
This facility serves as one of the two national referral centre’s for tuberculosis and is the largest
designated tuberculosis centre in Europe. This study was evaluated by the ethics committee
and was waived in accordance with Dutch legislation owing to its retrospective nature (Univer-
sity Medical Centre Groningen, METc number 2014/325). No written informed consent was
obtained from patients for the use of retrospective data but patient information was anon-
ymized and de-identified prior to analysis.
Statistical Analysis
Data was collected in and analyzed with SPSS (version 2.22) and descriptive statistics were
used for the diagnosis and MDRO screening results. Data is presented as mean (SD) or median
with 25–75% inter quartile range (IQR) as appropriate. General data was obtained from the
patients’ file. When the date of arrival was only mentioned the year, either the 1st July or 1st of
January was entered based on the information available.
The association between the number of days in the Netherlands and performing a screening
for MDRO was calculated by Mann-Whitney-U test.
Results
Study Population and Group Characteristics
Between April 1st 2014 through September 1st 2015 care was provided to 736 asylum seekers
in our university hospital. We included 273 patients who presented at the emergency ward or
were admitted to the ward for further analysis. General characteristics can be found in Table 1.
Most people originated from Eritrea (36.5%) or Syria (18.6%). Thirty-three (12%) asylum seek-
ers were babies born in the Netherlands.
Infectious Diseases in Asylum Seekers
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The median number of days in the Netherlands before presentation in the hospital was 74
(IQR 24–283). Many of the patients (32%) were admitted to the hospital or presented to the
emergency department within the first 4 weeks after arrival in the Netherlands. Fourteen
patients were admitted within the first week of arrival: 10 of whom were admitted within the
first three days after arrival. In 56% (n = 153) no arrival date was reported in the patient docu-
mentation. Patients were admitted for a median duration of 7 (IQR2-26) days.
Purpose of Hospital Visit
130 patients were admitted with an infectious disease of which 23% presented with vivax
malaria (n = 30) and 34% proved to have pulmonary tuberculosis (n = 44). Three patients with
pulmonary tuberculosis had drug resistant tuberculosis: one patient with MDRTB (from Geor-
gia), one patient with XDRTB (from Latvia) and one patient with INH resistant pulmonary
tuberculosis who originates from Syria but lived in both the Ukraine and Libya before seeking
asylum in the Netherlands. 186 patients presented with non-infectious disease, with 22%
(n = 40) associated with pregnancy, childbirth and post-partum care, 11% (n = 22) with dis-
eases of the circulatory system and 12% with injury, poisoning and other consequences of
external cause (n = 21). The diseases asylum seekers presented with are described in detail in
Table 2. Eleven admitted patients were coinfected with HIV.
Multi Drug Resistant Organisms
Of the 130 patients tested, 31% (n = 40) had one or more MDRO cultured, in total 52 MDROs.
ESBL expressing E. coli (n = 20) was the most common MDRO. Additionally four K. pneumo-
niae and oneM.morganii and one E. cloacae were found ESBL positive. Thirteen from the 26
ESBL positive Enterobacteriaceae were resistant to fluoroquinolones and at least one of the
aminoglycosides (both tobramycin and gentamicin were tested). Genes encoding for CTX-M-
1-like, CTX-M-15-like, and CTX-M-9 group ESBLs were detected in 13 (50%), 6 (23%), and 5
(19%) isolates, respectively. SHV 238S/240K was detected in one isolate. In one isolate with
Table 1. General characteristics of asylum seekers admitted or presenting at the emergency
department.
Number of asylum seekers
Male (%) 184 (67%)
Days in the Netherlands Median (IQR)* 74 (22–247)
Age median (IQR) 24 (15–33)
Country of origin
Eritrea (%) 92 (36.5)
Syria (%) 47 (18.6)
Afghanistan (%) 8 (3.2)
Armenia (%) 21 (8.3)
Nigeria (%) 7 (2.8)
Other, Africa (%) 38 (15.1)
Other, Asia (%) 21 (8.3)
Other, Middle East (%) 12 (4.8)
Other, Europe (%) 5 (2)
Other, South America (%) 1 (0.4)
Missing (%) 21 (8.3)
*In 153 patients, arrival date in the Netherlands had not been recorded
doi:10.1371/journal.pone.0154791.t001
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ESBL phenotype no resistance genes were detected by DNA array. Sixteen Enterobacteriaceae
(mainly E. coli) were resistant to aminoglycosides and fluoroquinolones without ESBL. One E.
coli isolate was resistant to colistin. No carbapenemase-producing Enterobacteriaceae were
found. With respect to gram positive MDROs, only ten patients were found to carry MRSA.
MDRO carriage appeared to be higher among people from Syria than from Eritrea (7/13 vs
14/64, RR 2.46 (95% CI: 1.24–4.88)). Carriage of a MDRO was significantly associated with a
shorter duration of stay in the Netherlands: median days in the Netherlands of those with
MDRO was 26 (IQR: 4–87) days versus those without MDRO 85 (IQR: 27–316) days,
P<0.001. No MDRO was cultured in asylum seekers’ babies born in the Netherlands (n = 9).
Discussion
Around half of the asylum seekers admitted at our university hospital presented with an infec-
tious condition. The carriage rate of MDRO in asylum seekers was 31%. Carriage rate varied by
Table 2. Purpose of visit; infectious and non-infectious diseases.
Infectious diseases Number
(%)
Bacterial; pulmonary tuberculosis (n = 44), suspected tuberculosis (n = 9) intestinal
tuberculosis (n = 1), tuberculous peritonitis (n = 1), relapsing fever Borrelia recurrentis (n = 2)
57 (43.8)
Parasitic; malaria (P. vivax n = 28, P. falciparum n = 2), leishmaniasis (n = 1),
schistosomiasis (n = 2), (scabies n = 7)
40 (30.8)
Clinical presentation of an infection, not otherwise speciﬁed; fever, diarrhoea, abscess,
respiratory infection, perinatal infection, deep infection of the ﬁnger, viral infection, tonsillitis,
gastroenteritis, pharyngitis, eosinophilia
17 (13.1)
Viral; viral bronchiolitis (n = 2), viral respiratory infection (n = 1), hepatitis C (n = 9),
cytomegalovirus (n = 1), disseminated Varicella Zoster Virus infection (n = 2)
15 (11.5)
Fungus; nasopharyngeal candida 1 (0.8)
Total 130 (100)
Non infectious diseases Number
(%)
pregnancy, childbirth and the puerperium 40(21.5)
injury, poisoning and certain other consequences of external causes 23(12.4)
diseases of the circulatory system 22(11.8)
certain conditions originating the perinatal period 19(10.2)
genitourinary system 14(7.5)
diseases of the nervous system 12(6.4)
endocrine, nutritional and metabolic diseases 9(4.8)
external causes of morbidity and mortality 8(4.3)
diseases of the musculoskeletal system and connective tissue 5(2.7)
diseases of the digestive system 5(2.7)
diseases of the blood and immune system 5(2.7)
diseases of the eye and adnexa 4(2.1)
diseases of the ear and mastoid process 4(2.1)
congenital malformations, deformations and chromosomal abnormalities 4(2.1)
Neoplasms 4 (2.1)
mental and behavioural disorders 4(2.1)
diseases of the respiratory system 3(1.6)
diseases of the skin and subcutaneous tissue 3(1.6)
Total 186 (100.0)
doi:10.1371/journal.pone.0154791.t002
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the patients’ country of origin and the duration of stay in the Netherlands, however, no CPE
was detected.
Given the number of asylum seekers presenting at the national registration centre in Ter
Apel, up to 800 daily, the number of admitted patients or patients referred to the emergency
department at our university medical centre was low considering the likely adverse conditions
during transit.
The most common infectious diseases patients presented with in our hospital were tubercu-
losis and P. vivaxmalaria. An increase in P. vivaxmalaria in newly arrived Eritrean asylum
seekers has been noticed before in Sweden and Norway and its increase seems related to the
migration route [19].
The high number of tuberculosis patients in our study results both from a higher incidence
in many countries of origin, from the screening by X-ray at arrival in the national reception
centre in Ter Apel, and from the asylum seekers with tuberculosis referred by other hospitals in
the Netherlands to the UMCG tuberculosis centre. Patients also presented with diseases that
are less common such as leishmaniasis or even more seldomly diagnosed in Europe such as the
LBRF. After the two patients who reported to our hospital with LBRF [20] additional patients
were reported in Switzerland [21] and Germany [22]. Because of the short incubation period
the infection is likely to present quickly after arrival and thus at hospitals near to the single
national registration centre.
Knowledge about infectious diseases and carriage of MDRO’s in asylum seekers is urgently
needed to provide adequate care and to enable optimal hospital hygiene strategies. The carriage
of MDRO in asylum seekers is high when compared to the Dutch population and also correlates
to the carriage rate in country of origin as expected. Asylum seekers have a carriage rate of resis-
tant Enterobacteriaceae comparable to Dutch inhabitants travelling abroad who are similarly
known to import multi-drug resistant pathogens. Travellers from the Netherlands showed a
high carriage rate of 30.5% of extended-spectrum β-lactamase-producing Enterobacteriaceae
(ESBL-E) after their return from Asia, Africa or South America [23]. It should be considered
whether screening policies should not only focus on asylum seekers, but also to consider screen-
ing Dutch patients admitted after international travels to Asia, Africa or South America as well.
As an important fact, no CPE was found in asylum seekers. This is different to expectation, as
regions of surrounding the country of origin of the asylum seekers are reported to have high
prevalence of CPE [24]. As the prevalence of CPE is rising in other European countries, espe-
cially in South Europe, but also Germany, asylum seekers that have been treated in hospitals in
those countries might get colonized during their travel to the Netherlands. Screening activities
needs to be enhanced in order to identify CPE-carriers early. A recent study from Germany
showed CPE-carriers and found a multidrug-resistant Gram-negative bacteria carriage rate of
almost 61% [25] which is much higher than the MDRO carriage rate in our study. A higher
background rate of MDRO in Germany, differences in travel routes and origin of asylum seekers
and morbidity on admission, may all have contributed to the difference in MDRO carriage rate.
The aim of this study was to identify and list infectious diseases and carriage of high-risk
potential pathogens that may have consequences for public health and infection control. We
did not describe details of the non-communicable diseases asylum seekers presented with even
though we realize that treatment of these non-communicable diseases are challenging consid-
ering the need of optimal compliance and follow-up [26].
The selection of asylum seekers in our hospital based on the insurance number is practical
and ensures a complete selection of study participants. Selection based on information in the
medical files is likely to be incomplete and selection based on the patients’ address leads to
exclusion of asylum seekers do not live in the asylum centres or who have been transferred to
other centres. The geographical location close to the single national registration centre ensures
Infectious Diseases in Asylum Seekers
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a true reflection of infectious diseases entering the Netherlands, especially considering the
short incubation period from some of the infectious diseases.
Only the diagnoses at admissions were included because of their immediate importance for
hospital hygiene measures. Purpose of visits to the out-patient clinic was not reported in this
study. Psychiatric disorders are common in asylum seekers [27]. In our study, only four
patients were admitted due to psychiatric disorders. However, most likely this low number
does not reflect the actual prevalence; Most frequently, in the Netherlands, these patients are
referred to specialised regional units for transcultural psychiatry.
Another limitation to the study is the percentage of asylum seekers screened at admission.
Screening of admitted asylum seekers or asylum seekers presenting at the emergency department
was only partially implemented and as a result screening was only done in 48% of the patients.
Additional screenings is needed to identify the risk factors for carriage of MDRO strains. These
additional screenings will also provide more details on the antimicrobial resistance. Further typ-
ing of the MDROmay provide information on the likely route of transmission.
In conclusion, asylum seekers frequently present with infectious diseases, of which many
have consequences for infection control. Hospital staff should be prepared to recognize uncom-
mon, poverty-related infectious diseases, especially in hospitals seeing patients who have
recently arrived in the Netherlands. A close collaboration with the municipal health centre’s
and the general practitioners at the asylum centres enables a rapid response to new events.
Screening for MDRO at admission is necessary at least for originating countries with a high
background rate of MDRO to enable the optimal treatment for patients and optimal strategy
for infection control.
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